3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Biofrontera Bioscience GmbH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage Ameluz, Sciton HEROic - Actinic Keratoses, Photodamage | Phase 1 | Completed | Sherrif Ibrahim | 10 | 2025-06-27 | 2026-01-02 |
| Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp BF-200 ALA and red light LED lamp - Actinic Keratosis, Keratosis, Actinic | Phase 1 | Completed | Biofrontera Bioscience GmbH | 112 | 2021-12-01 | 2024-10-17 |
| Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK) BF-200 ALA and red light LED lamp - Actinic Keratoses | Phase 1 | Completed | Biofrontera Bioscience GmbH | 48 | 2020-03-05 | 2021-11-11 |
Keratosis, Actinic (3) · Keratosis (1) · Precancerous Conditions (1) · Skin Diseases (1)
BF-200 ALA (2) · Aminolevulinic Acid (1)
United States (3)